Found 107 matching trials
A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL) PHASE1 Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Show More Location
Southampton University Hospitals NHS Tust
Learn More & Join Trial
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment PHASE2 The primary objective of this study is to evaluate the safety of zanubrutin...
Show More Location
Rocky Mountain Cancer Centers (Williams) Usor
Learn More & Join Trial
A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects PHASE1 This study will be a 2-part, open-label, single-center relative bioavailabi...
Show More Learn More & Join Trial
Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial. PHASE2 Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Show More Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Learn More & Join Trial
Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL PHASE1 This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) comp...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Mosunetuzumab for CLL MRD Clearance PHASE1 The goal of this study is to test mosunetuzumab given alone or in combinati...
Show More Location
Brigham & Women's Hospital
Learn More & Join Trial
Cardiotoxicities in Patients Receiving BTKi N/A This is a multicenter, prospective, observational cohort study to comprehen...
Show More Location
Multiple Locations
Learn More & Join Trial
National Acalabrutinib Observational Study N/A The efficacy and safety of acalabrutinib in the treatment of patients with ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL PHASE2 This study is to determine the response to acalabrutinib in patients with c...
Show More Learn More & Join Trial
A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma PHASE2 This phase II trial compares three chemotherapy regimens consisting of bend...
Show More Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial